-
公开(公告)号:US20230263883A1
公开(公告)日:2023-08-24
申请号:US18014947
申请日:2021-07-08
发明人: Stephen J. Elledge , Ellen Shrock , Eric Fujimura
IPC分类号: A61K39/215 , C07K16/10 , A61K49/00 , G01N33/569
CPC分类号: A61K39/215 , C07K16/10 , A61K49/0004 , G01N33/56983 , G01N2333/165 , G01N2469/20
摘要: Peptide epitopes identified in subjects infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and methods of use thereof for diagnosing, determining prognosis, and treating Coronavirus Disease 2019 (COVID-19), and developing prophylactic or therapeutic vaccines against SARS-CoV-2.
-
公开(公告)号:US20220362285A1
公开(公告)日:2022-11-17
申请号:US17875831
申请日:2022-07-28
IPC分类号: A61K31/737 , A61P3/10 , A61K47/38
摘要: This disclosure relates to compositions including formulated sucralfate or other aluminum-crosslinked sulfated agents for delivery of agents to biological surfaces and/or the modulation of nutrient absorption through the intestinal lining as well as methods for the manufacture of and the use of these compositions for treating disorders including diabetes type II and clinical obesity that require a modulation of certain nutrients to the body.
-
公开(公告)号:US20220290104A1
公开(公告)日:2022-09-15
申请号:US17828393
申请日:2022-05-31
发明人: Dhvanit I. Shah
IPC分类号: C12N5/0789 , A61K35/28
摘要: In some aspects and embodiments, the invention provides methods for making hematopoietic stem cells, including for HSCT. The method comprises providing a cell population comprising hemogenic endothelial (HE) or endothelial cells, and increasing activity or expression of DNA (cytosine-5-)-methyltransferase 3 beta (Dnmt3b) and/or GTPase IMAP Family Member 6 (Gimap6) in the HE and/or endothelial cells under conditions sufficient for stimulating formation of HSCs.
-
公开(公告)号:US20210324058A1
公开(公告)日:2021-10-21
申请号:US17290960
申请日:2019-11-05
IPC分类号: C07K16/18
摘要: Anti-NEDD9 antibodies and methods of making and using said antibodies.
-
公开(公告)号:US20200061162A1
公开(公告)日:2020-02-27
申请号:US16348383
申请日:2017-11-09
摘要: Compositions and methods for treating cancer that include administering a therapeutically effective amount of a tumor suppressor mRNA complexed with a delivery vehicle as described herein, e.g., a nanoparticle.
-
公开(公告)号:US20200054583A1
公开(公告)日:2020-02-20
申请号:US16609048
申请日:2018-04-26
IPC分类号: A61K31/137 , A61K31/216 , A61P1/00 , A61K9/00
摘要: Methods and compositions for the treatment of conditions associated with pharyngeal airway muscle collapse while the subject is in a non-fully conscious state, e.g., sleep apnea and snoring, comprising administration of a norepinephrine reuptake inhibitor (NRI) and a muscarinic receptor antagonist.
-
公开(公告)号:US20190314399A1
公开(公告)日:2019-10-17
申请号:US16349715
申请日:2017-11-14
IPC分类号: A61K31/7105 , A61P35/00 , A61K31/713 , C12Q1/6886 , A61K38/17
摘要: Provided herein are methods for the prevention and treatment of an abnormal tissue condition in the liver (e.g., liver cancer) of a subject, based on the administration of an inhibitor of a G protein-coupled estrogen receptor 1 (GPER1).
-
公开(公告)号:US20190203256A1
公开(公告)日:2019-07-04
申请号:US16298521
申请日:2019-03-11
IPC分类号: C12Q1/04 , A61B5/08 , G01N33/497 , A61B5/00
CPC分类号: C12Q1/04 , A61B5/08 , A61B5/082 , A61B5/14546 , A61B5/4836 , G01N33/497 , G01N2033/4975 , G01N2333/38 , G01N2800/18 , G01N2800/26 , G01N2800/52
摘要: Methods for diagnosing, treating, and monitoring the treatment of invasive aspergillosis (IA) are described. The methods can include detecting the presence of one or more volatile organic compounds (VOCs) in the breath of subjects suspected of having IA.
-
公开(公告)号:US09884129B2
公开(公告)日:2018-02-06
申请号:US14589037
申请日:2015-01-05
IPC分类号: A01N63/00 , A61K47/48 , A61K38/18 , A61K31/573 , A61K31/704 , A61K35/28 , C12N5/0775 , A61K47/69
CPC分类号: A61K47/6937 , A61K31/573 , A61K31/704 , A61K35/28 , A61K38/1816 , A61K47/6921 , A61K47/6935 , C12N5/0662
摘要: A composition includes an isolated cell; at least one particle within said cell; and at least one active agent associated with the particle, wherein the active agent is capable of being released from the cell. A method includes administration of such a cell to a subject.
-
公开(公告)号:US20180023142A1
公开(公告)日:2018-01-25
申请号:US15699546
申请日:2017-09-08
发明人: Howard Weiner , Oleg Butovsky , Merit Cudkowicz , James Berry
IPC分类号: C12Q1/68 , C12N15/113
CPC分类号: C12Q1/6883 , C12N15/113 , C12N2310/113 , C12N2310/3231 , C12Q2600/158 , C12Q2600/178
摘要: Provided herein are methods of treating a neurodegenerative disorder such as Amyotrophic Lateral Sclerosis (ALS) or Multiple Sclerosis (MS) that include administering to a subject at least one inhibitory nucleic acid that decreases the level or activity of microRNA has-miR-155.
-
-
-
-
-
-
-
-
-